NVS—ODAC votes 10-0 in favor of CTL019—(CAR-T)—in pediatric ALL: http://raps.org/Regulatory-Focus/News/2017/07/12/28073/FDA-Panel-Votes-Unanimously-in-Favor-of-First-CAR-T-Cancer-Therapy/